EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Emerging role of sialylation in cancer therapy resistance: Mechanisms and therapeutic implications

Rebecca E Farrell, Kell A Stelzer, Guo-Jun Liu, Danielle Skropeta

Drug Resistance Updates · 2025-11 · 83 · 101285

DOI: 10.1016/j.drup.2025.101285 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Drug Resistance Updates, 2025-11. Verfasst von Rebecca E Farrell und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Science, Faculty of Science, Medicine and Health, University of Wollongong, Wollongong, NSW 2522, Australia. Hauptthemen laut MEDLINE: Neoplasms, Drug Resistance, Neoplasm, Sialyltransferases, Antineoplastic Agents. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 164 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Tour de Cure, Australian Institute of Nuclear Science and Engineering.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Resistance to existing cancer therapies is a major factor contributing to cancer's persistence as a global health challenge. Abnormal sialylation patterns, commonly due to changes in the expression of sialyltransferases (STs) is a well-established property of tumour cells. There is a growing body of evidence to demonstrate that sialylation is involved in resistance to chemotherapy, targeted therapy, radiotherapy and immunotherapy through a variety of mechanisms that are still being unveiled. In this review, we summarise the reported correlations between aberrant sialylation and cancer therapy resistance, the underlying mechanisms discovered thus far, and progress made in targeting sialylation to enhance responsiveness to cancer treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsDrug Resistance, NeoplasmSialyltransferasesAntineoplastic AgentsN-Acetylneuraminic AcidHumansAnimalsImmunotherapyMolecular Targeted Therapy

Stichwörter der Autor:innen

CancerNeuraminidaseSialylationSialyltransferaseTherapy resistance

Substanzen

SialyltransferasesAntineoplastic AgentsN-Acetylneuraminic Acid

Autor:innen und Institutionen

  • School of Science, Faculty of Science, Medicine and Health, University of Wollongong, Wollongong, NSW 2522, Australia.
  • Australian Nuclear Science and Technology Organisation, Lucas Heights, NSW 2234, Australia; Discipline of Medical Imaging Sciences, Brain and Mind Centre, Faculty of Medicine and Health, The University of Sydney, Sydney…
  • School of Science, Faculty of Science, Medicine and Health, University of Wollongong, Wollongong, NSW 2522, Australia. Electronic address: skropeta@uow.edu.au.

Förderung

  • Tour de Cure
  • Australian Institute of Nuclear Science and Engineering

Zitieren

APA

Farrell, R. E., Stelzer, K. A., Liu, G. J., & Skropeta, D. (2025). Emerging role of sialylation in cancer therapy resistance: Mechanisms and therapeutic implications. Drug Resistance Updates, 83, 101285. https://doi.org/10.1016/j.drup.2025.101285

Vancouver

Farrell RE, Stelzer KA, Liu GJ, Skropeta D. Emerging role of sialylation in cancer therapy resistance: Mechanisms and therapeutic implications. Drug Resistance Updates. 2025;83:101285. doi:10.1016/j.drup.2025.101285

BibTeX
@article{Farrell2025,
  author = {Farrell, Rebecca E and Stelzer, Kell A and Liu, Guo-Jun and Skropeta, Danielle},
  title = {Emerging role of sialylation in cancer therapy resistance: Mechanisms and therapeutic implications},
  journal = {Drug Resistance Updates},
  year = {2025},
  volume = {83},
  pages = {101285},
  doi = {10.1016/j.drup.2025.101285}
}
Kostenlos starten →